Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Long-term outcome of Simpson IV meningioma resection: Would it improve with adjuvant SRS

M. Dedeciusova, M. Majovsky, L. Pecen, V. Benes, D. Netuka

. 2021 ; 207 (-) : 106766. [pub] 20210617

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc22012311
E-zdroje Online Plný text

NLK ProQuest Central od 2002-01-01 do Před 2 měsíci
Health & Medicine (ProQuest) od 2002-01-01 do Před 2 měsíci
Psychology Database (ProQuest) od 2002-01-01 do Před 2 měsíci

OBJECTIVE: Subtotal meningioma resection (STR) is often performed to minimize surgical morbidity. Nevertheless, only a few studies have reported on patient outcome after STR. We studied the long-term outcome of SIV (Simpson grade IV) resection and identified predictive factors of overall survival (OS), progression-free survival (PFS) and time to progression (TTP). METHODS: A retrospective analysis was performed on 68 patients who underwent SIV resection of meningioma (grade I) from 2004 to 2010. Data were collected from clinical, surgical and pathology records and radiological imaging. Long-term outcomes were evaluated at least 10 years after surgery. RESULTS: Permanent morbidity was 11.8%, 30-day mortality 2.9% and progression rate 50.0% for a median follow-up duration of 126.6 months. Median TTP was 86.2 months. Adjuvant SRS was the only significant factor associated with longer PFS (p = 0.0052) and TTP (p = 0.0079). Higher age (p = 0.0022), KPS (p = 0.0182), postoperative ECOG score (p = 0.0182) were reliable predictors of shortened OS and aSRS (p = 0.0445) was reliable predictor of longer OS. CONCLUSION: STR in intracranial meningioma is still viable and often the only treatment option available in high-risk patients or high-risk tumors. Although surgical morbidity and mortality are high, the OS rate was 85.3% at 5 years and 79.4% at 10 years. Because of the considerable progression rate and rather a long term OS the adjuvant SRS should be considered following SIV resection.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22012311
003      
CZ-PrNML
005      
20220506125839.0
007      
ta
008      
220425s2021 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.clineuro.2021.106766 $2 doi
035    __
$a (PubMed)34166979
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Dedeciusova, Michaela $u Department of Neurosurgery and Neurooncology, First Faculty of Medicine, Charles University and Military University Hospital, Prague, Czech Republic; First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic. Electronic address: michaela.dedeciusova@seznam.cz
245    10
$a Long-term outcome of Simpson IV meningioma resection: Would it improve with adjuvant SRS / $c M. Dedeciusova, M. Majovsky, L. Pecen, V. Benes, D. Netuka
520    9_
$a OBJECTIVE: Subtotal meningioma resection (STR) is often performed to minimize surgical morbidity. Nevertheless, only a few studies have reported on patient outcome after STR. We studied the long-term outcome of SIV (Simpson grade IV) resection and identified predictive factors of overall survival (OS), progression-free survival (PFS) and time to progression (TTP). METHODS: A retrospective analysis was performed on 68 patients who underwent SIV resection of meningioma (grade I) from 2004 to 2010. Data were collected from clinical, surgical and pathology records and radiological imaging. Long-term outcomes were evaluated at least 10 years after surgery. RESULTS: Permanent morbidity was 11.8%, 30-day mortality 2.9% and progression rate 50.0% for a median follow-up duration of 126.6 months. Median TTP was 86.2 months. Adjuvant SRS was the only significant factor associated with longer PFS (p = 0.0052) and TTP (p = 0.0079). Higher age (p = 0.0022), KPS (p = 0.0182), postoperative ECOG score (p = 0.0182) were reliable predictors of shortened OS and aSRS (p = 0.0445) was reliable predictor of longer OS. CONCLUSION: STR in intracranial meningioma is still viable and often the only treatment option available in high-risk patients or high-risk tumors. Although surgical morbidity and mortality are high, the OS rate was 85.3% at 5 years and 79.4% at 10 years. Because of the considerable progression rate and rather a long term OS the adjuvant SRS should be considered following SIV resection.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a meningeální nádory $x mortalita $x patologie $x chirurgie $7 D008577
650    _2
$a meningeom $x mortalita $x patologie $x chirurgie $7 D008579
650    _2
$a lidé středního věku $7 D008875
650    _2
$a stupeň nádoru $7 D060787
650    _2
$a doba přežití bez progrese choroby $7 D000077982
650    _2
$a radiochirurgie $7 D016634
650    _2
$a adjuvantní radioterapie $7 D018714
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a míra přežití $7 D015996
650    _2
$a časové faktory $7 D013997
650    _2
$a výsledek terapie $7 D016896
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Majovsky, Martin $u Department of Neurosurgery and Neurooncology, First Faculty of Medicine, Charles University and Military University Hospital, Prague, Czech Republic; First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic
700    1_
$a Pecen, Ladislav $u Institute of Computer Science, The Czech Academy of Sciences, Prague, Czech Republic
700    1_
$a Benes, Vladimir $u Department of Neurosurgery and Neurooncology, First Faculty of Medicine, Charles University and Military University Hospital, Prague, Czech Republic; First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic
700    1_
$a Netuka, David $u Department of Neurosurgery and Neurooncology, First Faculty of Medicine, Charles University and Military University Hospital, Prague, Czech Republic; First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic
773    0_
$w MED00001144 $t Clinical neurology and neurosurgery $x 1872-6968 $g Roč. 207, č. - (2021), s. 106766
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34166979 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220425 $b ABA008
991    __
$a 20220506125831 $b ABA008
999    __
$a ok $b bmc $g 1789759 $s 1163512
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 207 $c - $d 106766 $e 20210617 $i 1872-6968 $m Clinical neurology and neurosurgery $n Clin Neurol Neurosurg $x MED00001144
LZP    __
$a Pubmed-20220425

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...